These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19895744)

  • 1. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of survivin mRNA in urine exfoliated cells of patients with bladder transitional cell carcinoma detected by real-time PCR].
    Sun J; Hou JQ; He J; He XF; Wen DG
    Ai Zheng; 2009 Oct; 28(10):1100-2. PubMed ID: 19799821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
    Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
    Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
    Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
    Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
    Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
    Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
    Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
    Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of survivin and its splice variants in gastric cancer.
    Cheng Z; Hu L; Fu W; Zhang Q; Liao X
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):393-8. PubMed ID: 17828494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma.
    Vandghanooni S; Eskandani M; Montazeri V; Halimi M; Babaei E; Feizi MA
    J Cancer Res Ther; 2011; 7(3):325-30. PubMed ID: 22044815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a real-time quantitative polymerase chain reaction method for the quantification of 3 survivin transcripts and evaluation in breast cancer tissues.
    Pavlidou A; Kroupis C; Goutas N; Dalamaga M; Dimas K
    Clin Breast Cancer; 2014 Apr; 14(2):122-31. PubMed ID: 24325949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
    Ling X; Yang J; Tan D; Ramnath N; Younis T; Bundy BN; Slocum HK; Yang L; Zhou M; Li F
    Lung Cancer; 2005 Sep; 49(3):353-61. PubMed ID: 15936846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer.
    Wu Y; Wang G; Wei J; Wen X
    Indian J Med Sci; 2005 Jun; 59(6):235-42. PubMed ID: 15988093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR.
    Pavlidou A; Dalamaga M; Kroupis C; Konstantoudakis G; Belimezi M; Athanasas G; Dimas K
    World J Gastroenterol; 2011 Mar; 17(12):1614-21. PubMed ID: 21472129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the survivin-2B splice variant related to the progression of colorectal carcinoma.
    Cho GS; Ahn TS; Jeong D; Kim JJ; Kim CJ; Cho HD; Park DK; Baek MJ
    J Korean Surg Soc; 2011 Jun; 80(6):404-11. PubMed ID: 22066067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of survivin splicing variants in expression gastric cancer].
    Meng H; Dai DJ; Lu CD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):234-6. PubMed ID: 16167236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.
    Schultz IJ; Kiemeney LA; Witjes JA; Schalken JA; Willems JL; Swinkels DW; de Kok JB
    Anticancer Res; 2003; 23(4):3327-31. PubMed ID: 12926071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.